Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy

Biomaterials
Ariel BierChaya Brodie

Abstract

Duchenne muscular dystrophy (DMD) is a degenerative lethal, X-linked disease of skeletal and cardiac muscles caused by mutations in the dystrophin gene. Cell therapy using different cell types, including mesenchymal stromal cells (MSCs), has been considered as a potential approach for the treatment of DMD. MSCs can be obtained from autologous sources such as bone marrow and adipose tissues or from allogeneic placenta and umbilical cord. The safety and therapeutic impact of these cells has been demonstrated in pre-clinical and clinical studies and their functions are attributed to paracrine effects that are mediated by secreted cytokines and extracellular vesicles. Here, we studied the therapeutic effects of placenta-derived MSCs (PL-MSCs) and their secreted exosomes using mouse and human myoblasts from healthy controls, Duchenne patients and mdx mice. Treatment of myoblasts with conditioned medium or exosomes secreted by PL-MSCs increased the differentiation of these cells and decreased the expression of fibrogenic genes in DMD patient myoblasts. In addition, these treatments also increased the expression of utrophin in these cells. Using a quantitative miR-29c reporter, we demonstrated that the PL-MSC effects were partly media...Continue Reading

References

Mar 7, 2002·Lancet·Alan E H Emery
Mar 28, 2002·Physiological Reviews·Derek J BlakeKay E Davies
Dec 3, 2002·Nature·Sasha BogdanovichTejvir S Khurana
Apr 19, 2006·Journal of Cellular Biochemistry·Arnold I Caplan, James E Dennis
Apr 25, 2006·Experimental Cell Research·Ida Rasmusson
Nov 17, 2006·Nature·Maurilio SampaolesiGiulio Cossu
Apr 18, 2007·Molecular and Cellular Biology·Huating WangDenis C Guttridge
Feb 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Kyla D HuebnerJudy E Anderson
Dec 1, 2009·Lancet Neurology·Katharine BushbyUNKNOWN DMD Care Considerations Working Group
Jul 30, 2011·Skeletal Muscle·Christopher J MannPura Muñoz-Cánoves
Sep 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuko Nitahara-KasaharaShin'ichi Takeda
Feb 4, 2012·Cold Spring Harbor Perspectives in Biology·C Florian BentzingerMichael A Rudnicki
Mar 22, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lijun WangHuating Wang
Mar 30, 2012·Frontiers in Physiology·Andrea NoetelMargarete Odenthal
Oct 24, 2012·Immunology and Cell Biology·Karen English
Sep 10, 2013·EMBO Molecular Medicine·Christopher R HeierKanneboyina Nagaraju
Nov 16, 2013·Experimental & Molecular Medicine·Matthew B MurphyArnold I Caplan
Apr 12, 2015·FEBS Letters·Yoshihiro NakamuraMitsuo Ochi
Apr 22, 2015·Biochimica Et Biophysica Acta·Simona ZanottiMarina Mora
May 20, 2015·Stem Cell Reports·Patrizia PessinaPura Muñoz-Cánoves
Sep 20, 2015·Human Molecular Genetics·Thomas C RobertsMatthew J A Wood
Oct 8, 2015·Nature Communications·Donald G PhinneyLuis A Ortiz
Nov 17, 2015·Nature Medicine·Nicolas A DumontMichael A Rudnicki
Dec 10, 2015·Nature Medicine·Alexandra C Keefe, Gabrielle Kardon
Aug 21, 2016·Human Genetics·Jacqueline N Robinson-Hamm, Charles A Gersbach
Oct 18, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Rinat MeirRachela Popovtzer
Dec 13, 2016·Expert Opinion on Biological Therapy·Erik H Niks, Annemieke Aartsma-Rus
Feb 7, 2017·Nature Reviews. Immunology·James G Tidball
May 10, 2017·Current Opinion in Pharmacology·Simon Guiraud, Kay E Davies

❮ Previous
Next ❯

Citations

Aug 23, 2018·Human Gene Therapy·Francesco GalliGiulio Cossu
Jun 4, 2019·Journal of Bone and Mineral Metabolism·Denton E ConnorDevendra K Agrawal
Nov 15, 2019·Current Pharmaceutical Design·Chao TuZhihong Li
Mar 19, 2020·Cells·Carolina BalbiSveva Bollini
Jun 17, 2020·The American Journal of Sports Medicine·Shama R IyerRichard M Lovering
Jun 2, 2020·Frontiers in Bioengineering and Biotechnology·Edoardo MaghinSveva Bollini
Mar 23, 2019·Stem Cell Research & Therapy·Shuzhi Teng, Ping Huang
Feb 16, 2019·Stem Cells International·Quan ZhuangYingzi Ming
Dec 17, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Oshra BetzerRachela Popovtzer
Oct 14, 2020·Tissue Engineering. Part a·Elham PishavarSang Jin Lee
Dec 18, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ling LengHaiFang Yin
Jan 27, 2021·Stem Cell Research & Therapy·Yuko Nitahara-KasaharaTakashi Okada
Jan 23, 2021·Pharmaceutics·Rebekah Omarkhail Elliott, Mei He
Dec 15, 2020·World Journal of Stem Cells·Hui-Kang XuCharlie Xiang
Nov 27, 2020·Frontiers in Cell and Developmental Biology·Riccardo BazzoniMauro Krampera
Dec 19, 2020·Biomedicines·Daria D NamestnikovaKonstantin N Yarygin
Feb 23, 2021·Frontiers in Bioengineering and Biotechnology·Anna CargnoniOrnella Parolini
Mar 7, 2021·International Journal of Molecular Sciences·Evgeniya E BurkovaGeorgy A Nevinsky
Mar 16, 2021·Frontiers in Pharmacology·Wumei WeiXiaohong Tian
Apr 4, 2021·International Journal of Molecular Sciences·Enzo ManchonReem Al-Daccak
Feb 25, 2021·Surgical Technology International·Chukwuweike GwamXue Ma
Apr 17, 2021·Frontiers in Bioengineering and Biotechnology·Jiawei ZhaoYugang Wang
May 1, 2021·Reproductive Biology·Prasad Pethe, Vaijayanti Kale
Jun 8, 2021·Frontiers in Bioengineering and Biotechnology·Martina SandonàValentina Saccone
Jul 14, 2021·Journal of Translational Medicine·Soudeh MoghadasiMostafa Jarahian
Jul 17, 2021·Human Molecular Genetics·Melanie GartzMichael W Lawlor
Oct 5, 2021·Frontiers in Cell and Developmental Biology·Donald H PenningChaya Brodie
Oct 9, 2021·Cell Stem Cell·Mauro Krampera, Katarina Le Blanc
Nov 6, 2021·Cancer Cell International·Xiuyun XuanChangzheng Huang
Nov 9, 2021·ACS Omega·Katerina ShamalovCyrille J Cohen
Dec 18, 2021·Journal of Extracellular Vesicles·Su-Ran LiGang Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.